Literature DB >> 16936699

Regulation of cardiac hypertrophy by intracellular signalling pathways.

Joerg Heineke1, Jeffery D Molkentin.   

Abstract

The mammalian heart is a dynamic organ that can grow and change to accommodate alterations in its workload. During development and in response to physiological stimuli or pathological insults, the heart undergoes hypertrophic enlargement, which is characterized by an increase in the size of individual cardiac myocytes. Recent findings in genetically modified animal models implicate important intermediate signal-transduction pathways in the coordination of heart growth following physiological and pathological stimulation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16936699     DOI: 10.1038/nrm1983

Source DB:  PubMed          Journal:  Nat Rev Mol Cell Biol        ISSN: 1471-0072            Impact factor:   94.444


  790 in total

1.  NADPH oxidase-4 mediates protection against chronic load-induced stress in mouse hearts by enhancing angiogenesis.

Authors:  Min Zhang; Alison C Brewer; Katrin Schröder; Celio X C Santos; David J Grieve; Minshu Wang; Narayana Anilkumar; Bin Yu; Xuebin Dong; Simon J Walker; Ralf P Brandes; Ajay M Shah
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-04       Impact factor: 11.205

2.  Cardiac-specific mindin overexpression attenuates cardiac hypertrophy via blocking AKT/GSK3β and TGF-β1-Smad signalling.

Authors:  Ling Yan; Xiang Wei; Qi-Zhu Tang; Jinghua Feng; Yan Zhang; Chen Liu; Zhou-Yan Bian; Lian-Feng Zhang; Manyin Chen; Xue Bai; Ai-Bing Wang; John Fassett; Yingjie Chen; You-Wen He; Qinglin Yang; Peter P Liu; Hongliang Li
Journal:  Cardiovasc Res       Date:  2011-06-01       Impact factor: 10.787

Review 3.  Cardiac hypertrophy and heart failure development through Gq and CaM kinase II signaling.

Authors:  Shikha Mishra; Haiyun Ling; Michael Grimm; Tong Zhang; Don M Bers; Joan Heller Brown
Journal:  J Cardiovasc Pharmacol       Date:  2010-12       Impact factor: 3.105

4.  Automated image analysis identifies signaling pathways regulating distinct signatures of cardiac myocyte hypertrophy.

Authors:  Gregory T Bass; Karen A Ryall; Ashwin Katikapalli; Brooks E Taylor; Stephen T Dang; Scott T Acton; Jeffrey J Saucerman
Journal:  J Mol Cell Cardiol       Date:  2011-12-01       Impact factor: 5.000

5.  Calcium, calpains, and cardiac hypertrophy: a new link.

Authors:  Felix M Heidrich; Barbara E Ehrlich
Journal:  Circ Res       Date:  2009-01-30       Impact factor: 17.367

6.  Toll-interacting protein (Tollip) negatively regulates pressure overload-induced ventricular hypertrophy in mice.

Authors:  Yi Liu; Xiao-Li Jiang; Yu Liu; Ding-Sheng Jiang; Yan Zhang; Rui Zhang; Yingjie Chen; Qinglin Yang; Xiao-Dong Zhang; Guo-Chang Fan; Hongliang Li
Journal:  Cardiovasc Res       Date:  2013-11-26       Impact factor: 10.787

7.  MITF interacts with the SWI/SNF subunit, BRG1, to promote GATA4 expression in cardiac hypertrophy.

Authors:  Gaurav Mehta; Sivarajan Kumarasamy; Jian Wu; Aaron Walsh; Lijun Liu; Kandace Williams; Bina Joe; Ivana L de la Serna
Journal:  J Mol Cell Cardiol       Date:  2015-09-24       Impact factor: 5.000

8.  IL-6 loss causes ventricular dysfunction, fibrosis, reduced capillary density, and dramatically alters the cell populations of the developing and adult heart.

Authors:  Indroneal Banerjee; John W Fuseler; Arti R Intwala; Troy A Baudino
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-02-20       Impact factor: 4.733

Review 9.  [Pathophysiology of heart failure].

Authors:  T Kempf; H Drexler; K C Wollert
Journal:  Internist (Berl)       Date:  2007-09       Impact factor: 0.743

10.  Mitochondrial fission is required for cardiomyocyte hypertrophy mediated by a Ca2+-calcineurin signaling pathway.

Authors:  Christian Pennanen; Valentina Parra; Camila López-Crisosto; Pablo E Morales; Andrea Del Campo; Tomás Gutierrez; Pablo Rivera-Mejías; Jovan Kuzmicic; Mario Chiong; Antonio Zorzano; Beverly A Rothermel; Sergio Lavandero
Journal:  J Cell Sci       Date:  2014-04-28       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.